By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    learn to recognize and treat yeast infections
    Most Commonly Asked Questions About Yeast Infections
    November 17, 2021
    Advanced lung cancer diagnosis systems used by doctors
    Advanced Lung Cancer Diagnosis Systems Used by Doctors
    March 6, 2022
    The Top Benefits of a Wearable Blood Pressure Monitor Watch
    The Top Benefits of a Wearable Blood Pressure Monitor Watch
    June 13, 2022
    Latest News
    7 Most Common Healthcare Accreditation Programs: Which Should You Use?
    August 20, 2025
    Hospital Pest Control and the Fight Against Superbugs
    August 20, 2025
    Hygiene Beyond The Clinic: Attention To Overlooked Non-Clinical Spaces
    August 13, 2025
    5 Steps to a Promising Career as a Healthcare Administrator
    August 3, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Life Expectancies and Lethal Injections
    May 6, 2015
    The Future of Healthcare and Big Pharma is in Big Data Analytics
    February 5, 2021
    Financial Assistance for Clinical Trials
    September 16, 2015
    Latest News
    How Social Security Disability Shapes Access to Care and Everyday Health
    August 22, 2025
    How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
    August 22, 2025
    How One Fall Can Lead to a Long Road of Medical Complications
    August 22, 2025
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Avastin Hearing — live blogging
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > FDA Avastin Hearing — live blogging
Policy & Law

FDA Avastin Hearing — live blogging

gooznews
gooznews
Share
2 Min Read
SHARE

The two-day hearing on Genentech’s appeal of the Food and Drug Administration’s decision to remove the breast cancer indication from Avastin’s label began with two hours of emotional testimony from breast cancer patients, their physicians and advocacy groups, most (but not all) of whom back continued approval of the drug. Anecdotal evidence isn’t science, and most of the women who testified self-identified themselves as super-responders who were different from most women with advanced metastatic breast cancer on the drug.

The two-day hearing on Genentech’s appeal of the Food and Drug Administration’s decision to remove the breast cancer indication from Avastin’s label began with two hours of emotional testimony from breast cancer patients, their physicians and advocacy groups, most (but not all) of whom back continued approval of the drug. Anecdotal evidence isn’t science, and most of the women who testified self-identified themselves as super-responders who were different from most women with advanced metastatic breast cancer on the drug. What can never be known is whether these particular women would have responded just as well in the absence of Avastin. What is known is that the aggregate data in the clinical trials that will be discussed later in the day does not show any increased survival benefit from use of the $8,000-a-month drug.

Listening to the poignant stories of individuals continuing to care for children, visit grandchildren, and climb mountains, a common thread emerged from their stories: please, they asked, don’t remove the indication from the label because then the insurance company won’t pay for it. That’s why the testimony of Bob Erwin, president of the Marti Nelson Cancer Foundation, struck me as the most relevant comment during the two-hour session. “Why,” he asked, “is a discussion between price and product performance off limits to the FDA?”

 

More Read

Romney’s Pre-Ex Plan
Your Ultimate Guide to Choosing the Perfect Medicare Plan
Social Media Laws – Really?
Immunotherapy: The Next Revolution In Cancer Treatment
Child Abuse and Its Impact on Public Health: A Call to Action
TAGGED:Avastinbreast cancerFDAhealth care policy
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

engineer fitting prosthetic arm
How Social Security Disability Shapes Access to Care and Everyday Health
Health care
August 20, 2025
a woman explaining the document
How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
Public Health
August 20, 2025
physiotherapist at work
How One Fall Can Lead to a Long Road of Medical Complications
Health care
August 20, 2025
Common Healthcare Accreditation Programs
7 Most Common Healthcare Accreditation Programs: Which Should You Use?
Health News
August 20, 2025

You Might also Like

BusinessHealth careHospital AdministrationMarketingMedical EducationMedical InnovationsMedical RecordsTechnologyUncategorized

The Importance Of Medical Labels And Supplement Labels

February 4, 2020

Cigarette Makers Sue the FDA Over New Labeling Rules

August 17, 2011

Innovating Medicaid for Healthcare Reform

October 28, 2012

Electronic Medical Records: Should the SEC Track the Brokerage Accounts of Hospital Clerks?

April 12, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?